Updated Results From An Open-Label Phase 1/2 Study Of Favezelimab In Combination With Pembrolizumab In Patients With Anti-Pd-1-Naive Relapsed Or Refractory Classical Hodgkin Lymphoma
Favezelimab;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updated Results From An Open-Label Phase 1/2 Study Of Favezelimab In Combination With Pembrolizumab In Patients With Anti-Pd-1-Naive Relapsed Or Refractory Classical Hodgkin Lymphoma ### Output: Favezelimab;Pembrolizumab